IL107454A - Pharmaceutical preparations containing imidazol-1-il compound - Google Patents

Pharmaceutical preparations containing imidazol-1-il compound

Info

Publication number
IL107454A
IL107454A IL10745493A IL10745493A IL107454A IL 107454 A IL107454 A IL 107454A IL 10745493 A IL10745493 A IL 10745493A IL 10745493 A IL10745493 A IL 10745493A IL 107454 A IL107454 A IL 107454A
Authority
IL
Israel
Prior art keywords
compounds
imidazol
methyl
colon
acid addition
Prior art date
Application number
IL10745493A
Other languages
English (en)
Hebrew (he)
Other versions
IL107454A0 (en
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of IL107454A0 publication Critical patent/IL107454A0/xx
Publication of IL107454A publication Critical patent/IL107454A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL10745493A 1992-11-14 1993-11-01 Pharmaceutical preparations containing imidazol-1-il compound IL107454A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4238553A DE4238553A1 (de) 1992-11-14 1992-11-14 Neue Imidazol-1-yl-Verbindungen enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
IL107454A0 IL107454A0 (en) 1994-02-27
IL107454A true IL107454A (en) 1999-12-22

Family

ID=6472938

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10745493A IL107454A (en) 1992-11-14 1993-11-01 Pharmaceutical preparations containing imidazol-1-il compound

Country Status (24)

Country Link
US (1) US5438068A (xx)
EP (1) EP0601345B1 (xx)
JP (1) JP3683286B2 (xx)
KR (1) KR100266715B1 (xx)
CN (1) CN1041053C (xx)
AT (1) ATE143597T1 (xx)
AU (1) AU667243B2 (xx)
CA (3) CA2504502A1 (xx)
CZ (1) CZ284154B6 (xx)
DE (2) DE4238553A1 (xx)
DK (1) DK0601345T3 (xx)
DZ (1) DZ1726A1 (xx)
ES (1) ES2092206T3 (xx)
GR (1) GR3021230T3 (xx)
HK (1) HK1006537A1 (xx)
HU (1) HU213506B (xx)
IL (1) IL107454A (xx)
MX (1) MX9307079A (xx)
NO (1) NO303926B1 (xx)
NZ (1) NZ250103A (xx)
PH (1) PH30702A (xx)
RU (1) RU2125877C1 (xx)
SK (1) SK278874B6 (xx)
ZA (1) ZA938463B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
US6365743B1 (en) 1995-10-13 2002-04-02 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
DE19813661A1 (de) * 1997-08-01 1999-02-04 Solvay Pharm Gmbh Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US7015333B2 (en) * 2002-11-18 2006-03-21 Solvay Pharmaceuticals B.V. Process for preparation of imidazolyl compounds
EP1424337A1 (en) * 2002-11-26 2004-06-02 Solvay Pharmaceuticals GmbH 4-hydroxy derivatives of 5,6,9,10-tetrahydro-10-((2-methyl-1h-imidazol-1-yl)methyl)-4h-pyrido-(3,2,1-jk)-carbazol-11(8h)-one
AU2004204825B2 (en) * 2003-01-13 2007-07-19 Dynogen Pharmaceuticals, Inc. Method of treating functional bowel disorders
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0201165B1 (en) * 1985-03-14 1994-07-20 Beecham Group Plc Medicaments for the treatment of emesis
EP0297651B1 (en) * 1987-06-29 1993-11-03 Duphar International Research B.V Anellated indole derivatives

Also Published As

Publication number Publication date
HUT65978A (en) 1994-08-29
IL107454A0 (en) 1994-02-27
US5438068A (en) 1995-08-01
SK123593A3 (en) 1994-09-07
NO934090L (xx) 1994-05-16
DK0601345T3 (da) 1996-11-18
ES2092206T3 (es) 1996-11-16
HK1006537A1 (en) 1999-03-05
SK278874B6 (sk) 1998-04-08
JPH06211656A (ja) 1994-08-02
CZ284154B6 (cs) 1998-08-12
CZ236593A3 (en) 1994-05-18
GR3021230T3 (en) 1997-01-31
NO303926B1 (no) 1998-09-28
CA2538177A1 (en) 1994-05-15
ZA938463B (en) 1994-08-01
CA2102960C (en) 2005-08-02
KR940010999A (ko) 1994-06-20
MX9307079A (es) 1994-05-31
JP3683286B2 (ja) 2005-08-17
HU213506B (en) 1997-07-28
NO934090D0 (no) 1993-11-12
EP0601345A1 (de) 1994-06-15
KR100266715B1 (ko) 2000-09-15
RU2125877C1 (ru) 1999-02-10
PH30702A (en) 1997-09-16
CN1041053C (zh) 1998-12-09
CA2102960A1 (en) 1994-05-15
CA2504502A1 (en) 1994-05-15
AU667243B2 (en) 1996-03-14
ATE143597T1 (de) 1996-10-15
EP0601345B1 (de) 1996-10-02
NZ250103A (en) 1997-06-24
DZ1726A1 (fr) 2002-02-17
DE59304045D1 (de) 1996-11-07
AU5064393A (en) 1994-05-26
CN1092650A (zh) 1994-09-28
DE4238553A1 (de) 1994-05-19

Similar Documents

Publication Publication Date Title
AU2019202884B2 (en) Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
DK174146B1 (da) Anvendelse af azabicyclocarboxylsyreester- eller amidsubstitueret indol eller benzothiophen
US5438068A (en) Method of treating colon disturbances with pharmaceutical compositions containing imidazol-1-yl compounds
WO2014054880A1 (ko) 신규한 폴리에틸렌글리콜과 비타민 씨를 함유하는 안정성이 개선된 장관 하제 조성물
WO1996032948A1 (en) Method for treating dyskinesias
US5525605A (en) Remedy for inflammatory intestinal diseases
US20220362353A1 (en) Drug combination for preventing or treating irritable bowel syndrome
CA2301679A1 (en) Medication for treatment of functional distrubances or illnesses of the lower intestinal tract, particularly abdominal visceral pain which accompanies them
EP0831835B1 (en) Treating anorexia
EP1203582A1 (en) Medicinal compositions for treating lower uropathy
US6251896B1 (en) Compositions and methods for the management of Crohn's disease
JPH01221316A (ja) 脳循環代謝改善剤
RU2121347C1 (ru) Лекарственный препарат
AU1284697A (en) Method for treating excessive aggression
EP0408108A2 (en) Pharmaceutical compositions containing acrylic acid derivatives and their use in the medicine
JPH11222433A (ja) 過敏性腸症候群の予防または治療薬
JPH0352855A (ja) アクリル酸塩、それらの製造方法、それらを含む薬剤組成物および医学におけるそれらの用途
HU206616B (en) Process for producing pharmaceutical compositions containing pharmaceutically active tetrahydro-naphtalene derivative
JPH10218767A (ja) 骨疾患治療剤

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees